1Perou CM,Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797):747- 752.
2Rakha EA,EI-Sayed ME,Green AR, et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109 (1): 25-32.
3Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes[J]. Clin Cancer Res, 2007, 13(8): 2329-2334.
4Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basaHike subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10 (16):5367-5374.
5Srlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J]. Proc Natl Acad Sci USA, 2001, 98(9): 10869-10874.
6Van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome[J]. Am J Pathol, 2002, 161(6): 1991-1996.
7Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms[J]. BMC Genomics, 2006, 7: 96.
8Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets[J]. Proc Natl Acad Sci USA, 2003, 100(14): 8418-8423.
9Reis-Filho JS, Milanezi F, Carvaiho S, et al. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis[J]. Breast Cancer Res, 2005, 7(6): R1028-R1035.
10Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours[J]. Histopathology, 2006, 49(1): 10-21.
3Ferrari N,Paleari L,Palmisnao G L,et al.Induction of apoptosis by fenretinide in tumor cell lines correlate dwith DLX-2,DLX-3,andDLX-4 gene expression[J].Oncol ReP,2003,10(4):973-977.
4Man Y,Fu S,Schwartz A,et al.Expression of BP1,a novel homeobox gene,correlates with breast cancer progression and invasion[J].Breast Cancer Research and Treatment,2005,90(3):241-247.
5Fu S W,Schwartz A,Stevenson H,et al.Correlation of expression of BP1,a homeobox gene,with estrogen receptor status in breast cancer[J].Breast Cancer Res,2003,5(4):R82-R87.
6Rakha E A,El-Sayed M E,Green A R,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25-32.
7Doane A S,Danso M,Lal P,et al.An estrogen recptor-negative breast cancer subset characterized by a homonally regulated transcriptional program and response to androgen[J].Oncogene,2006,25(28):3994-4008.
8Perou CM,S rlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
9Nanda R.“Targeting”triple-negative breast cancer:the lessons from BRCA1-associated breast cancers[J].Semin Oncol,2011,38(2):254-262.
10Tan DS,Marchio C,Jones RL et al.Triple negative breast cancer:molecular profiling and prognostic impact in adjuvant anthracycline-treated patients[J].Breast Can-cer Res Treat,2008,111(1):27-44.
